Ciprofloxacin-induced immune-mediated thrombocytopenia: No cross-reactivity with gemifloxacin.

Sim, D W; Yu, J E; Jeong, J; Koh, Y-I

Sim, D W; Yu, J E; Jeong, J; Koh, Y-I.

Afiliação

Sim DW; Division of Allergy, Asthma and Clinical Immunology, Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea.
Yu JE; Division of Allergy, Asthma and Clinical Immunology, Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea.
Jeong J; Division of Allergy, Asthma and Clinical Immunology, Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea.
Koh YI; Division of Allergy, Asthma and Clinical Immunology, Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea.

J Clin Pharm Ther ; 43(1): 134-136, 2018 Feb.

Article em En | MEDLINE | ID: mdl-28791716

Assuntos

Anti-Infecciosos/efeitos adversos; Ciprofloxacina/efeitos adversos; Fluoroquinolonas/uso terapêutico; Naftiridinas/uso terapêutico; Trombocitopenia/induzido quimicamente; Idoso; Feminino; Gemifloxacina; Humanos; Pneumonia/tratamento farmacológico

Palavras-chave

ciprofloxacin; cross-reactivity; drug-induced immune thrombocytopenia; gemifloxacin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombocitopenia / Ciprofloxacina / Fluoroquinolonas / Anti-Infecciosos / Naftiridinas Limite: Aged / Female / Humans Idioma: En Revista: J Clin Pharm Ther Assunto da revista: FARMACIA / TERAPEUTICA Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google